News for IGG Inc (0799.HK)

Total Revenue: $2.74 billion, up by 9%.Profit: HKD330 million.Gross Billing in July: HKD550 million, highest in recent years.Viking Rise Billing: Exceeded $80

Aug 29, 2024 / 01:30AM GMTOperator Investors, friends, good morning. Welcome you to 2024 interim results and investors meeting of IGG. Today, our conference wil

Key Takeaways: CMGE Technology announced it was buying the international rights to the game “The Legend of Sword and Fairy” from Taiwan’s Softstar Entertainment The Chinese gaming company looks to be speeding up an overseas push to offset intense competition in its home market By Fai Pui

Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, June 27, 2024 /PRNewswire/ -- Harbour BioMed (the 'Company'; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announces that it has resubmitted the Biologics License Application (BLA) of batoclimab (HBM9161) to the National Medical Products Administration (NMPA) of China for the treatment of generalized myasthenia gravis (gMG).

Citi cuts IGG Inc. rating to neutral, lowers stock price target to HK$4

SHANGHAI & CAMBRIDGE, Mass. — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List (NRDL) released by…

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with LOQTORZI plus chemotherapy significantly prolongs survival in patients with recurrent or metastatic NPC...

–  LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...

Total product revenue of $68.9 million for the second quarter of 2023, representing 45% y-o-y growth; 53% y-o-y growth at constant exchange rateVYVGART®...

Key Takeaways: ZX Inc.’s revenue and profit both grew significantly in the first half of the year as frequent lockdowns sparked an online gaming craze The company had just 290 million yuan in cash and 2 billion yuan in net current liabilities at the end of June By Fai Pui